Viewing data from:

TROPICAMIDE

ANDA

TROPICAMIDE | A040064 | BAUSCH AND LOMB INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Tropicamide (2023)

Total Spending

$3K

Total Claims

246

Beneficiaries

223

Avg Cost/Unit

$1.50

Spending Trend

$31K(2019)→$3K(2020)→$6K(2021)→$4K(2022)→$3K(2023)

YoY Change:+7.1%

5yr CAGR:+11.8%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain3 active DMFs5 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

TOKYO CHEMICAL INDUSTRY CO LTDTROPICAMIDE USP

DMF 109811994

UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)TROPICAMIDE

DMF 178002004

C-SQUARED PHARMA LTDTROPICAMIDE

DMF 379872023

SANTEN PHARMACEUTICAL CO LTDInactiveTROPICAMIDE MYDRIATIC

DMF 52571983

AMCIS AGInactiveTROPICAMIDE

DMF 60061985

CARBOGEN AMCIS AGInactiveTROPICAMIDE

DMF 125961997

OKAMI CHEMICAL INDUSTRY CO LTDInactiveTROPICAMIDE

DMF 147432000

SHIONO FINESSE LTDInactiveTROPICAMIDE

DMF 149402000

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1%

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Jul 27, 1994

No patent or exclusivity listings for this strength.

Change History (1)

Recent changes detected for this application.

MODIFIEDApplicant Full Name7/1/2026

Bausch and Lomb Pharmaceuticals Inc updated its registered applicant name to Bausch and Lomb Inc for tropicamide ophthalmic product (NDA 040064).

Old: BAUSCH AND LOMB PHARMACEUTICALS INC

New: BAUSCH AND LOMB INC